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Abstract 
 
Introduction 
Previous studies of quality of life (QoL) in patients with abdominal aortic 
aneurysm (AAA) have used generic measures and the impact of AAA remains 
unclear.  There are also very few data on symptoms or treatment satisfaction for 
patients with AAA.  The aim of this study was to present preliminary data on 
QoL, symptoms and treatment satisfaction gathered using three new AAA-
specific patient-reported outcome measures (PROMs). 
 
Methods 
Patients with AAA were recruited from 5 NHS Trusts to complete 3 new PROMs: 
The AneurysmDQoL, AneurysmSRQ and AneurysmTSQ.  Patients were either 
under surveillance or had undergone AAA repair (open or endovascular) during 
the preceding 24 months.  Data were initially collected as part of a study 
assessing the psychometric properties of the new measures before being used in 
the observational analysis of outcomes presented here. 
 
Results 
Results, though largely non-significant, showed interesting trends. The impact of 
AAA repair on QoL appeared to worsen progressively after open aneurysm 
repair (OR) and improve progressively after endovascular repair (EVAR).  
Conversely, symptoms seemed to become progressively worse after EVAR and 
progressively better after OR.  Information and understanding were key sources 
of dissatisfaction prior to intervention, whilst postoperative dissatisfaction was 
related to bother from symptoms, follow-up and feedback about scan results. 
 
Conclusions 
Though a larger, prospective dataset is necessary to explore outcomes more fully 
with the new AAA-specific PROMs, the observational data presented here 
suggest there may be clinically important differences in the symptoms, impact on 
QoL and treatment satisfaction associated with open and endovascular 
aneurysm repair.  
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Introduction 
 
Collection of patient-reported outcome (PRO) data has been mandatory for four 
common surgical procedures in England since 2009 (hip replacement, knee 
replacement, hernia repair and varicose vein surgery),1 but the use of patient-
reported outcome measures (PROMs) in other areas of surgery is still not 
routine.  Previous efforts to assess patient-reported outcomes for patients with 
abdominal aortic aneurysm (AAA) have been hampered by the absence of any 
truly suitable measures and the impact of AAA on quality of life (QoL) and other 
PROs remains unclear.4 
 
The aim of this study was to present preliminary observational data on QoL, 
symptoms and treatment satisfaction in patients with AAA, using data collected 
during the validation of three new condition-specific questionnaires designed 
specifically for patients with AAA: These are the Aneurysm-dependent Quality of 
Life questionnaire (AneurysmDQoL); the Aneurysm Symptom Rating 
Questionnaire (AneurysmSRQ); and the Aneurysm Treatment Satisfaction 
Questionnaire (AneurysmTSQ). 2[reference to design paper to be included here 
in place of the present references to abstracts if both are to be published 
simultaneously] 
 
 
Methods 
 
All data presented here were primarily collected as part of a study assessing the 
psychometric properties of the three new tools and validating them for use by 
patients with AAA (reported separately).3  Once that process had confirmed the 
structure and validity of the questionnaires and identified reliable sub-scales, 
data were used to compute patients’ scores for QoL, symptoms and treatment 
satisfaction in this observational analysis of clinical outcomes in patients with 
AAA or following AAA repair. 
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Full details of the design and validation of the new aneurysm-specific PROMs are 
described elsewhere,2 3[reference to design and psychometric development 
paper to be included here in place of the present references to abstracts if 
published simultaneously or in advance of this paper] but in brief, the 
AneurysmDQoL (following psychometric validation) comprises 2 initial 
overview items relating to overall QoL and aneurysm-related QoL, followed by 
22 items covering multiple specific aspects of QoL. Twenty of these items can be 
combined into a single scale (the two items relating to work and finances are 
excluded from this as they were only found to be relevant to a small number of 
patients with AAA). Importantly, the AneurysmDQoL is ‘individualised’ in several 
ways. First, those items that may not be applicable to everyone (e.g. sex life, 
family life) can be designated ‘not applicable’ and not scored. For those items 
that are considered applicable by an individual, part (a) concerns the impact of 
AAA on the aspect of life in question, with potential scores ranging from -3 
(maximum negative impact) through 0 (no impact), to +1 (positive impact).   Part 
(b) of each item concerns the importance of this aspect of life to their QoL, with 
potential scores ranging from +3 (very important) to 0 (not at all important) - 
see design paper in this issue [ref to BJS as appropriate if this is published as 
companion to the design paper].2 The score for each item – the Weighted Impact 
(WI) - is then calculated by multiplying the ‘impact score’ by the ‘importance 
score‘ [Appendix 1].  This provides a highly personalised assessment of the 
impact of AAA on each aspect of an individual’s life and the importance of that 
impact for QoL.  An ‘Average Weighted Impact’ (AWI) score can then be 
calculated for each individual, i.e. the mean across all 20 applicable domains 
which can be combined in the scale, giving an indication of the overall impact of 
AAA on that individual’s QoL. 
 
The AneurysmTSQ is an 11-item measure for assessing patients’ satisfaction 
with their aneurysm treatment.  It has two subscales – the first suitable for both 
pre- and post-intervention patients, and the second applicable only to post-
intervention patients. The AneurysmTSQ items are each scored on a scale of 6 
(e.g. ‘very satisfied’) to 0 (e.g. ‘very dissatisfied’). 
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Finally, the AneurysmSRQ is a 44-item tool to assess whether patients 
experienced particular symptoms and how bothered they were by symptoms 
experienced. Bother scores for each item range from 1 (not at all) to 4 (‘a lot’).  A 
score of zero is given if the symptom was not experienced. The AneurysmSRQ 
contains a ‘Composite’ subscale that combines 24 of the individual items to 
provide a broad indicator of overall bother from symptoms [Appendix 2].  It also 
contains 6 symptom subscales that focus on more specific areas/groups of 
symptoms: Emotion; Appetite; Lower limb; Cognitive; General malaise; and 
Gastrointestinal. 
 
Patients were recruited from 5 UK NHS Trusts: St George’s University Hospitals 
NHS Foundation Trust; North Bristol NHS Trust; Worcester Acute Hospitals NHS 
Trust; Norfolk and Norwich University Hospitals NHS Foundation Trust; and 
University Hospital Southampton NHS Foundation Trust.  St George’s Hospital 
was the lead centre, providing large numbers of patients who had undergone 
endovascular aneurysm repair (EVAR), whilst all other centres were 
purposefully chosen for the study on the basis that they perform significant 
numbers of both open aneurysm repair (OR) and EVAR.  In each centre, 
members of the local clinical team retrospectively identified all patients 
(consecutive) who had undergone AAA repair (OR or EVAR) within the 
preceding 12 months (or the preceding 24 months in the case of University 
Hospital Southampton) and invited them to take part in the study.  Two centres 
(St George’s and Southampton) also identified a number of patients enrolled in 
preoperative surveillance of small AAAs.  The number of patients was 
determined by the requirements for the psychometric validation study: numbers 
required to power detection of inter-group differences in outcome could not be 
calculated in advance of first use of these new tools.  Participants were asked to 
complete a pack containing the three new condition-specific questionnaires (the 
AneurysmDQoL, the AneurysmSRQ and the AneurysmTSQ) together with a basic 
demographic questionnaire. Each participant completed the questionnaires on a 
single occasion (without help from clinicians) providing cross-sectional data 
from patients at various points in the treatment pathway, pre- and post-
intervention. 
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Statistical analyses 
 
Statistical analyses were carried out using SPSS v20.0 (IBM Corps, Armonk, NY).  
Inter-group comparisons were made using Mann-Whitney U tests, whilst 
multiple group comparisons were made using Kruskal-Wallis tests with 
Bonferroni correction as appropriate.  Data from 6 weeks and 3 months post-
intervention were excluded from analyses due to very small patient numbers in 
these groups (Table 1). 
 
Results  
 
A total of 297 patients were sent packs for completion, of whom 197 individuals 
(66%) completed and returned the questionnaires. Participant characteristics 
can be seen in Table 1.  Three patients were excluded from the analysis of results 
due to being extreme outliers, having undergone initial surgery more than 3yrs 
prior to questionnaire completion.  If patients failed to answer any item, they 
were excluded from analysis of that item and means calculated based on the 
number of valid responses to that item. 
 
 
Quality of life (AneurysmDQoL) 
 
Broad differences in QoL at various points in the treatment pathway were 
initially examined using mean Average Weighted Impact (AWI) scores, where 
more negative scores indicate greater negative impact on QoL. 
 
In patients who had undergone OR, the negative impact of AAA repair on QoL 
was seen to worsen progressively over time.  In EVAR patients, however, the 
negative impact on QoL was greatest at 12m post-intervention (and similar to 
that seen in the OR group) but then improved markedly by >12m post-
intervention (Fig 1).  However, none of the apparent differences between mean 
AWI scores at different time-points or between the two types of intervention 
were statistically significant.  To assess the aspects of QoL that were contributing 
to this apparent trend, mean ‘weighted impact’ (WI) scores were also calculated 
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for each item in the AneurysmDQoL [Appendix 3]. For patients who had 
undergone OR, the domains that appeared to contribute most to the worsening 
impact of AAA on QoL over time, were holidays, ability to do things physically, 
impact on sex life, feelings about the future, general health, physical discomfort 
and anxiety.  The trend was for all of these aspects of QoL to be more severely 
affected at >12m post-OR than at any other time-point, including pre-
intervention (Fig. 2). 
 
The domains that were seen to contribute most heavily to the negative impact of 
EVAR on QoL (and this was predominantly at 12m post-intervention), were 
friends/social life, doing things for others, household tasks, overall health, 
feelings about the future, ability to think quickly and clearly, and physical 
discomfort. 
 
Symptoms (AneurysmSRQ) 
 
The overall impact of symptoms related to AAA and its treatment was initially 
examined using the Aneurysm-SRQ ‘Composite’ symptom subscale.  Although 
this subscale does not contain all 44 items in the questionnaire (since 
psychometric validation demonstrated that it was not possible to group all 44 
items legitimately into a single scale), it does contain 24 items and provides the 
broadest available overview of patients’ experience of symptoms [Appendix 2]. 
 
There was a general trend for those who had undergone OR to report less bother 
from symptoms at later time points, whilst those who underwent EVAR reported 
more bother from symptoms as time went on.  At 6m post-intervention, patients 
reported a similar evel of symptoms to that reported by patients in the pre-
intervention group, irrespective of whether they had undergone OR or EVAR 
(Fig. 3). At 12m post-intervention, patients in both groups reported slightly less 
bother from symptoms than had been reported by the preoperative group, but 
by >12m post-intervention, those who underwent EVAR were reporting greater 
bother from symptoms (relative to the preoperative group), whilst those who 
had undergone OR were reporting less bother.   
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In order to explore the relative patterns in OR and EVAR more fully, we then 
examined the trends in scores for each of the 6 subscales of the AneurysmSRQ: 
Emotion; Appetite; Lower limb; Cognitive; General malaise; and Gastrointestinal.   
 
For three of these factors (emotion; lower limb; and cognitive), the trends over 
time were similar to those seen with the Composite symptom subscale.   For the 
factors reflecting appetite, general malaise and gastrointestinal symptoms, 
bother from symptoms broadly reduced over time to well below preoperative 
levels.   
 
Trends in mean scores for the individual items of the AneurysmSRQ were also 
assessed.  Mean scores for the individual items showed very few statistically 
significant differences across the different time-points, with only ‘tiredness or 
lethargy’ (item 1) and ‘indigestion or heartburn’ (item 38) seen to cause 
significantly less bother over time in the OR group, and only weight loss (item 
36) seen to cause significantly less bother over time in the EVAR group. 
 
However, analysis of the percentage of patients experiencing each symptom was 
more revealing:  In the OR group, patients reported most bother at 6m post-
intervention, with more than 20% of patients reporting ‘moderate’ or ‘severe’ 
bother from a large number of symptoms (Table 2).  Far fewer symptoms were 
rated as causing moderate or severe bother at 12m or >12m post-intervention.  
In the EVAR group the trend was largely reversed, with progressively more 
symptoms causing moderate or severe bother at later time-points (Table 2). 
 
Treatment satisfaction (AneurysmTSQ) 
 
Though there were no statistically significant differences in AneurysmTSQ item 
scores over time within either the OR or EVAR groups, the use of mean or 
median scores may obscure clinically important areas of dissatisfaction when a 
majority of participants are reporting high levels of satisfaction.   Since the aim 
was to identify sources of dissatisfaction (and therefore potential targets for 
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improvement), analysis of results from the AneurysmTSQ involved assessing the 
percentage of patients scoring 3 or less for each item at each time-point.  Since 
possible scores for each item range from 6 (very satisfied) to 0 (very 
dissatisfied), it was decided that using a threshold score of 3 or less would 
indicate the proportion of patients who were not satisfied with that aspect of 
care. 
 
Prior to intervention, more than 40% of participants were dissatisfied with the 
information they had received about their aneurysm and its treatment and also 
with their understanding of the treatment for their aneurysm.  Furthermore, 
more than 20% were dissatisfied with feedback about scan results and the 
amount of support they were receiving from healthcare professionals. 
 
By 6m post-intervention, less than 10% of participants in either OR or EVAR 
group were reporting dissatisfaction in these areas, though dissatisfaction due to 
discomfort was more common (26% after OR; 17% after EVAR), as was bother 
from side effects (32% after OR; 8% after EVAR). Nearly 20% of the OR group 
also expressed dissatisfaction with their follow-up at this time-point. 
 
At 12m post-intervention, a substantial number of patients in the OR group 
expressed dissatisfaction relating to discomfort (22%), bother with symptoms 
(26%) and follow-up (19%).  In the EVAR group, the most common areas of 
dissatisfaction were length of stay (15%) and bother from side-effects (14%). 
 
Beyond 12m post-intervention, follow-up was the main source of dissatisfaction 
for patients in the OR group (25% scoring ≤3), with feedback about scan results 
also (surprisingly) causing dissatisfaction (14%).  In the EVAR group, more than 
15% expressed dissatisfaction with feedback about scan results and the 
information they had been given about their treatment.  Follow-up was also a 
cause of dissatisfaction for more than 10% of the EVAR group at this time-point. 
 
Discussion 
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The aim of this study was to use three newly developed condition-specific 
instruments to assess symptoms, impact on QoL, and treatment satisfaction 
issues associated with AAA and its repair. Though the dataset analysed here was 
not collected primarily for the determination of outcomes (but rather to provide 
data for psychometric validation of the new questionnaires themselves), it has 
provided a number of interesting preliminary findings that are contrary to 
previous assumptions about the experiences of this patient population.   
 
The trends observed in AneurysmDQoL items scores suggested that the negative 
impact of AAA on QoL generally increased over time in the OR group and 
decreased over time in the EVAR group.  Though there were no statistically 
significant changes in AneursymDQoL AWI scores over time, the number of 
domains negatively impacted at different time-points is noteworthy. In the OR 
group 17 of 22 domains were more severely impacted in the group that was 
>12m post-intervention than in the pre-intervention group.  Conversely, in the 
EVAR group, 15 of 22 domains were less severely impacted in the group that was 
>12m post-intervention than in the preoperative group.  Furthermore, these 
trends were borne out by the trends in AWI score for the two groups.   
 
Despite little clear evidence to support the theory, it had long been assumed that 
OR patients experience greater negative impact on QoL in the early 
postoperative period than those who had undergone EVAR (due to the greater 
physical insult of OR) but then recover and surpass their EVAR counterparts as 
the physical aspects of the operation become less relevant and other factors such 
as concerns about the need for ongoing surveillance or reintervention begin to 
impact on the EVAR group. 5 6 These early data challenge this assumption. 
 
The pattern for symptoms was opposite to that seen for QoL.  Patients who had 
undergone EVAR reported more bother from symptoms as time went on and 
those who had undergone OR reported less bother over time.  Notably, at 12m 
post-intervention and beyond, EVAR patients were not only reporting increasing 
bother from symptoms, but these symptoms were almost exclusively physical - 
rather than the emotional or psychological issues which might have been 
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expected - and particularly related to pain and weakness of the legs and back.  
Even though clinicians might previously have predicted a certain amount of 
groin discomfort or even claudication following EVAR (particularly in those with 
coexistent peripheral arterial disease), few would probably have expected these 
symptoms to be experienced so commonly a year or more post-intervention, 
unless there had been recognised iatrogenic occlusion of one or both internal 
iliac arteries.  It was also notable, however, that a large proportion of patients 
under surveillance reported bother from back pain and calf pain prior to 
intervention.  This raises the question of whether such symptoms are incidental 
in this elderly population rather than being attributable to AAA or its repair.  
Nonetheless, their absence in the postoperative OR group would seem to 
contradict this suggestion and it may be that these symptoms are indeed more 
common than previously recognized – even preoperatively. 
 
The fact that the trends for symptoms and QoL were contrary to one another is 
interesting in itself, since symptoms and QoL might be expected to show some 
positive correlation.  Detailed re-examination of the data demonstrated that 
when all patients (i.e. all time-points; centres; operation types) are analysed as a 
single group the expected relationship between symptoms and QoL can indeed 
be demonstrated, with a moderate (0.438; p<0.005) positive correlation 
between summary symptom score and AWI.  It is a statistical phenomenon 
caused by disaggregation of the data into time-point groups (Simpson’s paradox) 
that makes the overall trends in QoL and symptoms appear contrary to the 
underlying relationship, though the trends are nonetheless genuine. 7 8 
 
The presence of some correlation between symptoms and QoL highlights the 
importance of identifying and addressing post-operative symptoms where they 
exist – particularly for EVAR patients who were previously thought to have very 
few postoperative symptoms.  Nonetheless, it also seems clear that symptoms 
are far from the sole determinant of QoL, with feelings about the future and 
impact on social life, family life, travel and relationships all showing marked 
contributions to the impact of AAA on QoL only some of which may be mediated 
by symptoms.  Whilst it may be less easy for clinicians to modify these aspects of 
Page 12 of 24
http://mc.manuscriptcentral.com/bjs
BJS
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
FOR REVIEW ONLY
life, their importance to patients means they should not be discounted and better 
understanding of patients’ broader QoL after aneurysm repair might ultimately 
influence both patient and clinician in their decision to proceed - particularly for 
smaller aneurysms. 
 
Though assessment of mean item scores in the Aneurysm-TSQ provided little 
evidence of dissatisfaction,, analysis of the number of patients with a score of 
three or less for each item proved far more revealing.  This identified a number 
of areas of dissatisfaction in both the EVAR and OR groups, with patients being 
less than satisfied with information provision and understanding in the 
preoperative group and side effects, follow-up and feedback about scan results 
for postoperative patients.  Perhaps surprisingly, the qualitative work conducted 
during the design of these new questionnaires suggested dissatisfaction with 
follow-up was mostly related to the absence of follow-up in the OR group rather 
than excessive or worrying follow-up in the EVAR group. 2 All of these areas 
represent potential targets for improvements in practice that may also have 
secondary effects on QoL, for example by reducing anxiety or pain or providing 
information about whether it is safe to travel by air or safe to resume sexual 
activity which may otherwise be avoided unnecessarily. 
 
There were some study limitations.  Though the overall cohort included nearly 
200 patients, separation of these patients by time-point and operation type 
resulted in the largest group being only 52 patients and all other groups having 
fewer than 30.  Indeed, the 6wk and 3m post-intervention groups were so small 
(largely for logistical reasons) that they were ultimately excluded from the 
analyses.  This is particularly relevant as it may be in this early postoperative 
period that differences in trends for OR and EVAR are most marked.  The small 
sub-groups also prevented the intended inter-centre comparisons as these 
would have required the groups to be split still further.  Consideration was given 
to grouping all patients from a particular centre together (irrespective of time-
point) in order to allow inter-centre comparison, but with evidence suggesting 
there was quite marked variation in questionnaire scores over time, it was 
decided that this would be of little value.  It is also notable that this work did not 
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include any analysis of, or statistical adjustment for, age, comorbidity, 
reintervention and other factors that might in themselves be related to QoL and 
symptom reporting, such as gender.  It can be seen that the mean age of the 
EVAR group is, not surprisingly, several years older than that of the OR group 
and some of the trend to increased reporting of symptoms in the EVAR group at 
>12 months may be explained by increasing age and associated comorbidity. 
Controlling for these variables would strengthen future work on larger samples 
of patients and allow robust regression analyses to establish which patient or 
treatment factors are significant determinants of QoL. 
 
It should also be appreciated that the data presented here were cross-sectional 
rather than longitudinal, and data collected at each time-point were from 
different patients.  Furthermore, a significant proportion of patients in the ‘>12m 
post-intervention’ group were from a single centre (Southampton) and this could 
also have influenced the observed trends.  Apparent changes in QoL, symptoms 
and treatment satisfaction over time must therefore be viewed with this in mind.  
Future work that follows individuals longitudinally will be able to gain a more 
detailed understanding of how QoL, symptoms and treatment satisfaction 
change for each individual over the course of their diagnosis and treatment.   
 
The preliminary results presented here provide one of the first disease-specific 
assessments of QoL, symptoms and treatment satisfaction of patients with AAA.  
Though a larger dataset is needed to explore the differences between OR and 
EVAR more fully and control for confounding variables, our results have shown 
trends that suggest that there may be clinically significant differences in the 
pattern of symptoms and QoL experienced by these two groups.  Our findings 
also highlight the potential importance of distinguishing between health status 
and QoL when assessing outcome, since the two constructs (represented here by 
symptoms and QoL) do not necessarily follow the same pattern of change. 
 
Whilst it is perhaps information on QoL and symptoms that ultimately informs 
changes in treatment or health policy, data on treatment satisfaction provide 
much more immediate targets for improvements in clinical care.  This study has 
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identified several areas including information, follow-up and management of 
postoperative pain that might be the initial focus of such improvements. Ongoing 
use of the Aneurysm-TSQ would also allow evaluation of any improvement 
strategies that are implemented.  
 
Though understanding of the true nature of patient reported outcomes for 
patients with AAA is still in the early stages, more detailed knowledge can now 
be gathered through wider routine use of these new AAA-specific measures.  
 
Access to questionnaires: visit www.healthpsychologyresearch.com 
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Table 1 – Patient subgroup characteristics 
 Open 
repair 
Endovascular 
repair 
Surveillance Total 
Mean age 
(range) 
 
72.7 
(60 – 89.5) 
76.6 
(60.5 - 95.6) 
78.0 
(58.8 – 90.7) 
- 
Gender 
- Male 
- Female 
- Missing/unknown 
 
67 
2 
- 
 
89 
14 
- 
 
16 
2 
1 
 
172 
18 
1 
Total 69 103 19 191 
Centre 
- St George’s 
- North Bristol 
- Worcester 
- Norfolk & Norwich 
- Southampton 
- Missing/unknown 
 
5 
3 
20 
18 
20 
3 
 
55 
8 
3 
13 
23 
1 
 
17 
- 
- 
- 
2 
- 
 
77 
11 
23 
31 
45 
4 
Total 69 103 19 191 
Time-point 
- Pre-intervention 
- 6wks postop (4-8wks) 
- 3m postop (9-16wks) 
- 6m postop (17-39wks) 
- 12m postop (40-65wks) 
- >12m postop (>66wks) 
 
- 
1 
2 
23 
27 
16 
 
- 
2 
5 
25 
52 
19 
 
19 
- 
- 
- 
- 
- 
 
19 
3 
7 
48 
79 
35 
Missing details    3* 
Overall total 69 103 19 194 
* 1 patient excluded at 6months and 2 patients excluded at 12months (out of original 
194 patients) due to being unsure about what type of operation they had undergone. 
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Table 2 - Symptoms for which more than 20% of patients reported moderate or severe bother 
 
Pre-intervention 
(OR/EVAR) 
(n=19) 
 
6m post-intervention 
(n=23) 
12m post-intervention 
(n=27) 
>12m post-intervention 
(n=16) 
 
Back pain/discomfort (47%) 
Pain/discomfort calves (42%) 
Weakness in legs (37%) 
Tired/lethargic (26%) 
Pain/discomfort/thighs (26%) 
Tingle/numbness in legs (26%) 
Heaviness in legs (26%) 
Abdominal pain (21%) 
Memory problems (21%) 
Difficulty concentrating (21%) 
Difficulty thinking quickly (21%) 
 
 
 
 
 
OR 
(%) 
 
Tired/lethargic (39%) 
Probs with sex func. (39%) 
Weight gain (35%) 
Back pain/discomfort (30%) 
Memory problems (26%) 
Abdominal pain (22%) 
Heaviness in legs (22%) 
Depressed/low (22%) 
Worried/nervous (22%) 
Irritable/angry (22%) 
Emotional/upset (22%) 
Episodes too hot/cold 
(22%) 
Sleep problems (22%) 
Indigestion (22%) 
Flatulence/belching (22%) 
 
 
Tired/lethargic (26%) 
Probs with sex func. (26%) 
 
 
Probs with sex. func. (25%) 
Episodes too hot/cold (25%) 
Sleep problems (25%) 
 
 
 
6m post-intervention 
(n=25) 
12m post-intervention 
(n=52) 
>12m post-intervention 
(n=19) 
EVAR 
(%) 
 
Weakness in legs (31%) 
Tired/lethargic (24%) 
Generally weak (24%) 
Episodes too hot/cold 
(24%) 
Flatulence/belching (24%) 
 
 
Tired/lethargic (31%) 
Pain/discomfort back (27%) 
Pain/discomfort thighs (27%) 
Pain/discomfort calves (25%) 
Tingle/numbness legs (23%) 
Sleep problems (25%) 
Flatulence/belching (23%) 
 
 
Tired/lethargic (47%) 
Pain/discomfort back (37%) 
Weakness in legs (32%) 
Unsteadiness (32%) 
Generally weak (26%) 
Pain/discomfort calves (26%) 
Difficulty concentrating (26%) 
Lost interest in sex (26%) 
Worried/nervous (21%) 
Irritable/angry (21%) 
Tingle/numbness in legs (21%) 
Difficulty thinking quickly (21%) 
Probs with sex func. (21%) 
Sleep problems (21%) 
Flatulence/belching (21%) 
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Figure 1 – Negative impact of AAA on QoL at different time-points following open repair (OR) or 
endovascular repair (EVAR).  
 
254x190mm (72 x 72 DPI)  
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Figure 2 – Aneurysm-Dependent Quality of Life (AneurysmDQoL) item scores at >12m post-intervention.  
254x190mm (72 x 72 DPI)  
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Caption : Figure 3 – Trends in mean scores for the Aneurysm Symptom Rating Questionnaire 
(AneurysmSRQ) ‘Composite’ symptom scale. Higher score indicates greater bother from symptoms.  
241x186mm (150 x 150 DPI)  
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Appendix 1 – Example of question format and scoring for the Aneurysm-Dependent Quality of 
Life Questionnaire (AneurysmDQoL) (scoring shown information only – not usually visible) 
 
 
5 (a) If I had never had an aneurysm, physically I could do: 
 -3 -2 -1 0 +1 
 very much more much more a little more the same less 
 (b) For me, how much I can do physically is: 
 +3 +2 +1 0 
 very important important somewhat important not at all important 
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Appendix 2 – items in the AneurysmSRQ ‘Composite’ symptom subscale 
 
Q1b Tired or Lethargic 
Q2b Headaches 
Q3b Feverish 
Q6b Pain discomfort groin 
Q8b Pain discomfort back 
Q9bAbdominal pain 
Q13b Depressed or low 
Q14b Feelings of panic 
Q15b Worried nervous 
Q16b Irritable angry 
Q17b Emotional upset 
Q18b Difficulty concentrating 
Q19b Memory problems 
Q20b Difficulty thinking quickly clearly 
Q21b Unsteady uncoordinated 
Q22b Dizzy/lightheaded 
Q24b Heaviness in legs 
Q25b Trembling e.g. limbs 
Q26b Weakness in legs 
Q29b Avoided sexual activity 
Q31b Excessive sweating 
Q32b Episodes too hot or too cold 
  Q34b Generally weak 
  Q40b Flatulence or belching 
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Appendix 3 – Mean Weighted Impact scores at various time-points in the treatment pathway 
(AneurysmDQoL 
 
 
OR/EVAR SD OR SD EVAR SD OR SD EVAR SD OR SD EVAR SD
(n=19) (n=23) (n=25) (n=27) (n=52) (n=16) (n=19)
WI Item 1 Leisure -1.26 2.10 -1.5 2.39 -0.54 1.25 -1.77 2.64 -1.02 1.65 -1.38 2.34 -0.79 1.03
WI Item 2 Work -1.5 2.12 -0.57 1.51 -0.5 1.23 -0.4 0.89 -0.57 0.98 -3.33 0.58 0 0.00
WI Item 3 Long Distance Journeys -0.94 1.96 -0.91 1.83 -0.92 2.10 -1.07 1.80 -1.06 2.13 -1.44 2.50 -0.5 1.10
WI Item 4 Holidays (NA=0) -1 1.56 -1.65 2.72 -1.3 2.54 -1.24 2.20 -1.63 2.25 -1.75 2.62 -0.57 1.22
WI Item 5 Do Physically -0.94 1.39 -2.5 2.99 -1.22 2.35 -2 2.35 -1.52 2.24 -2.43 3.16 -1.16 1.46
WI Item 6 Family Life (NA=0) -1.53 2.50 -1.64 3.00 -1.04 2.84 -1.65 2.76 -1.28 2.19 -1.38 2.50 -0.44 0.92
WI Item 7 Friendships & Social Life -0.89 2.26 -0.91 2.41 -0.64 2.20 -1.54 2.53 -1.47 2.54 -1.31 3.09 -0.42 0.77
WI Item 8 Closest Personal Relationship (N=0) -0.67 1.78 -1.25 3.07 -0.65 1.95 -0.68 1.32 -0.49 1.34 -1.21 2.78 -0.81 1.68
WI Item 9 Sex Life (NA=0) 0 0.00 -2.31 2.98 -1 3.03 -1.19 2.75 -1 1.81 -2.2 2.57 -0.58 0.90
WI Item 10 Getting Out & About -0.68 2.21 -1.14 2.46 -1.12 2.33 -1.37 1.88 -1.54 2.24 -1.44 2.66 -1 1.67
WI Item 11 Household Tasks -1.32 2.38 -1.41 1.97 -0.8 2.16 -1.52 2.31 -1.29 2.07 -1.19 2.40 -0.67 1.19
WI Item 12 Do Things For Others -1.05 2.25 -1.52 2.09 -0.36 1.22 -0.81 1.42 -1.31 2.12 -0.75 1.73 -0.74 1.66
WI Item 13 Enjoy Food -0.79 1.51 -0.52 1.90 0.04 0.74 -0.35 0.94 -0.46 1.15 -0.25 1.00 -0.21 0.92
WI Item 14 Feelings About The Future -1.79 3.05 -1.17 1.80 -0.88 2.28 -1.63 2.99 -1.23 2.15 -2.06 2.89 -0.53 0.84
WI Item 15 Finance -0.11 0.46 -0.14 0.83 -0.17 0.82 -0.15 0.53 -0.29 1.32 -1.5 2.45 0 0.00
WI Item 16 Having To Depend On Others -0.63 1.34 -1.61 2.33 -1.13 2.33 -1 1.90 -1.16 2.28 -1.19 2.48 -0.79 1.90
WI Item 17 Health -1.84 2.52 -1.83 2.89 -1.04 2.09 -1.42 2.10 -1.67 3.12 -1.94 3.02 -1.05 1.31
WI Item 18 Others Fuss or Worry -0.83 2.28 -1.26 1.84 -0.79 1.77 -1.04 1.82 -0.61 1.82 -0.94 1.29 -0.95 2.12
WI Item 19 Energy -1 1.56 -2.5 3.05 -1.24 2.45 -1.59 2.10 -1.92 2.82 -1.88 2.47 -1.58 2.27
WI Item 20 Physical Discomfort -0.68 1.34 -1.39 2.39 -0.84 2.06 -1.7 2.61 -1.43 2.67 -2.25 3.38 -0.53 1.31
WI Item 21 Anxiety -1.53 2.57 -1 1.57 -1.2 2.61 -1.63 2.47 -1.31 2.26 -2.44 3.33 -1 2.19
WI Item 22 Think Clearly, Concentrate & Remember -1.26 2.45 -1.43 2.15 -0.32 1.25 -1.04 2.16 -0.87 1.90 -1.38 3.32 -0.35 1.46
Preop mean 6m mean 12m mean >12m mean
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